Home » Healthcare » DNA Repair Drugs Market

Global DNA Repair Drugs Market By Drug Type (Olaparib, Rucaparib, Niraparib, Talazoparib, and Other Drug Types), By Application (Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Breast Cancer, and Other Application Types) Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the Report

How are the major segments performing in the DNA Repair Drugs market?

In 2022, the olaparib segment accounted for the largest market share as an increase in ovarian, breast, pancreatic, peritoneal, fallopian tube, and prostate cancer cases was increasing in demand.
In 2022, the ovarian cancer segment was anticipated to hold a prominent share in the global DNA repair drugs market as it is the most common cancer among women and the most common cancer overall, ovarian cancer is the most common cancer among women
In 2022, the hospital pharmacies segment accounted for the largest share of the market as there was an increase in the prevalence of cancer.

Which region dominated the DNA Repair Drugs market?

In 2022, the North American region was anticipated to hold a prominent share of the global DNA repair drugs market. As a result of increasing investments in DNA repair research, a greater focus on research and development, and an increasing prevalence of cancer disorders within the region, the market growth in the region has been fueled by these factors. In 2020, for example, 1,806,590 cases were diagnosed in the U.S., and the number of cancer survivors is expected to reach 2.2 million by 2030.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

How is US Market Performing in the DNA Repair Drugs market?

In 2022, the North American region was anticipated to hold a prominent share of the global DNA repair drugs market. As there are a greater number of patients with breast cancer in the U.S. as a result, the demand for DNA repair drugs is high. Furthermore, the increased investment in R&D has fueled the region’s market demand.

How is the economy impacting the global DNA repair drugs growth?

As a result of the COVID-19 pandemic, DNA repair drugs have been affected significantly. DNA repair drugs are mostly used in cancer treatments. Consequently, the delay in cancer treatment worldwide led to a significant decline in demand for these drugs after the outbreak of the pandemic began. An article published in May 2021 titled “Impact of COVID-19 on Cancer Care in India: A Cohort Study” claims that the COVID-19 epidemic has significantly affected oncology services in India and the progression of cancer stages and outcomes. It is likely that discontinuing cancer screening and delaying hospital visits will have long-term consequences.

What is the competitive environment of the DNA repair drugs market?

In this sector, the competitive environment provides information on the total economic profit made by suppliers and businesses, the sales and revenue generated in this sector, the global share of DNA repair drugs, the business organization summary, the introduction of new products, and market opportunities for DNA repair drugs. For instance, in June 2021, the invention of prexasertib, an inhibitor of DNA damage response, was licensed to Acrivon Therapeutics by Eli Lilly for worldwide commercialization. As part of its Phase II development program, Acrivon will advance a dual inhibitor of CHK1 and CHK2 of the second generation called ACR-368. Furthermore, in February 2021, With the launch of ART0380, Artios Pharma Limited is undertaking a clinical trial to test the efficacy of its small-molecule ATR inhibitor against advanced or metastatic solid tumors. In combination with established and novel agents which cause DNA damage and suppress cancer’s ability to repair DNA damage, ART0380 is being developed as an oral anti-cancer drug for treating malignancies harboring defects in DNA repair.

Executive Summary

What are the key trends in the DNA repair drugs market?

Several key players are adopting research and development investments and strategies to develop new products. This factor is expected to boost the growth of the DNA repair drugs market. For instance, Artios Pharma announced in April 2018 that its next step was to develop a nuclease inhibitor drug program aimed at commercializing novel treatments for cancers of the breast, ovary, and other organs. As governments in developing countries modernize their healthcare infrastructure, access to healthcare is likely to increase. Consequently, government initiatives to increase cancer awareness and its growing prevalence in developing countries create lucrative market opportunities.

How are Manufacturers Teaming Up with Stakeholders in the DNA repair drugs market?

There are several key players in the global DNA repair drugs market, explaining the market’s high concentration level. Many manufacturers hold major market shares in their respective regions. Due to the rising prevalence of cancer, the demand for technologically advanced products has increased in both emerging and developed markets. There will be a strong drive to the global market from growth strategies adopted by leading players. For instance, in May 2019, it was announced that Clovis Oncology, Inc. had initiated a phase II study with Bristol-Myers Squibb Company and Foundation Medicine Inc. to evaluate the combination of rucaparib and nivolumab for the treatment of high-grade serous carcinoma (HGSC) and endometroid ovarian cancer.

Which are the key investments by the DNA repair drugs market players?

DNA repair drug market players are expanding production capacities for DNA repair drugs in order to gain a competitive advantage. Furthermore, players are focusing on strategic mergers and acquisitions, collaborations and creating awareness among healthcare industries through different associations formed to promote smart, innovative practices in order to serve more end users in the domestic market. For instance, in July 2017, A clinical collaboration between Bristol-Myers Squibb and Clovis Oncology was established. To evaluate their combined effects on multiple tumor types, Rubraca (Rucaparib) and Opdivo (Nivolumab) will be evaluated in Phase 2 and Phase 3 clinical trials.

Some major players in the DNA repair drugs market are Onxeo, FoRx Therapeutics, Artios Pharma Limited, Merck KGaA, Debiopharm Group, Breakpoint Therapeutics, Luciole Pharmaceuticals, Repare Therapeutics, AstraZeneca Plc, AbbVie, Johnson & Johnson, Pfizer Inc., ClovisOncology Inc., and GlaxoSmithKline plc.

What are the Major Driving Factors for the DNA repair drugs market?

Cancer is one of the leading causes of death globally. People are suffering from various cancer diseases; thus, the global DNA repair drugs market is likely to grow due to the increase in cancer prevalence among the population. The development of new products and adaptation of strategies for developing them are also hallmarks of several key players’ research and development efforts. As a result of governments in developing countries investing in modernizing healthcare infrastructure, healthcare access is likely to increase. Thus, government initiatives to raise awareness about cancer and its growing prevalence create lucrative market opportunities.

What are the Major Risks for the DNA repair drugs market?

The delays in product approvals, which can have a negative impact on revenue generation and increase clinical trial costs, are a major hindrance to the market’s expansion. In addition, the high cost of DNA repair drugs hinders the market growth.

Which is the key drug type in the DNA repair drugs market?

The olaparib segment is expected to hold a prominent share of the global DNA repair drugs market during the forecast period. Lynparza is the brand name under which Olaparib is sold. In adults with advanced BRCA-mutated ovarian cancer, it is a PARP inhibitor that inhibits the enzyme poly ADP ribose polymerase, which is involved in DNA repair. Ovarian, breast, pancreatic, peritoneal, fallopian tube, and prostate cancers are a few major factors driving the segment’s growth. For instance, Ovarian cancer, for instance, is the eighth most common cancer in women according to the World Cancer Research Fund International. There were over 313,000 new cases in 2020.

How is the DNA repair drugs market performing in regions?

North America is anticipated to witness the fastest growth in the global DNA repair drugs market during the forecast period due to the presence of key players and the introduction of new products following the early adoption of technologically advanced products. Furthermore, due to increasing investments in DNA repair research, a greater focus on research and development, and an increasing prevalence of cancer disorders within the region, the market growth in the region has been fuelled by these factors.

What is the regulatory landscape for the DNA Repair Drugs market?

Understanding DNA repair pathways from a biological and regulatory perspective may facilitate the development of inhibitors of nuclear and mitochondrial DNA repair pathways for increasing the anticancer effect of DNA damage-based therapies. As regulations and government initiatives build the growth of the DNA Damage Response Drugs market, business owners can anticipate what to expect in the future.

What is the Market Size of DNA Repair Drugs regarding value?

The global DNA repair drugs market is anticipated to grow at a substantial CAGR of 22.10% in the upcoming years. The global DNA repair drugs industry was estimated to be worth USD 7,894.6 million in 2022 and was expected to be worth USD 31,940.36 million by 2028.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

What are the major players planning for the future of the DNA repair drugs market?

An increasing regional presence and investment in downstream applications are expected to give the company an advantage over its competitors. For instance, in October 2019, Janssen Pharmaceutical Companies’ niraparib was granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) to treat metastatic castration-resistant prostate cancers caused by the BRCA1/2 gene mutation. Furthermore, in April 2018, A new venture by Artios Pharma aimed to commercialize new cancer treatments targeting nuclease inhibitors aimed at the female breast and ovarian cancers.

REPORT ATTRIBUTE	DETAILS
DNA Repair Drugs Market by Value	Yes
DNA Repair Drugs Market, Tornado Analysis	Yes
DNA Repair Drugs Market, STAR Analysis	Yes
DNA Repair Drugs Market, SRC Analysis	Yes
DNA Repair Drugs Market Pricing Analysis	Yes (On Demand)
DNA Repair Drugs Market Segment Analysis	By Drug Type (Olaparib, Rucaparib, Niraparib, Talazoparib, and Other Drug Types) By Application (Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Breast Cancer, and Other Application Types) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Other Distribution Channel)
DNA Repair Drugs Market, Regional Analysis	North America (US and Canada) Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, India, Japan, South Korea, South East Asia, and the Rest of Asia Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) Middle East and Africa (GCC Countries, South Africa, and the Rest of Middle East and Africa)
DNA Repair Drugs Market Key Companies	Onxeo, FoRx Therapeutics, Artios Pharma Limited, Merck KGaA, Debiopharm Group, Breakpoint Therapeutics, Luciole Pharmaceuticals, Repare Therapeutics, AstraZeneca Plc, AbbVie, Johnson & Johnson, Pfizer Inc., ClovisOncology Inc., and GlaxoSmithKline plc.
DNA Repair Drugs Market Competitive Landscape	Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Major Strategies Adopted

Segmentation of Global DNA Repair Drugs Market-

Global DNA Repair Drugs Market – By Drug Types

Olaparib
Rucaparib
Niraparib
Talazoparib
Other Drug Types

Global DNA Repair Drugs Market – By Application

Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer
Breast Cancer
Other Application Types

Global DNA Repair Drugs Market – By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Other Distribution Channel

Global DNA Repair Drugs Market – By Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global DNA Repair Drugs Market
2.2. Global DNA Repair Drugs Market, By Drug Type
2.3. Global DNA Repair Drugs Market, By Application
2.4. Global DNA Repair Drugs Market, By Distribution Channel
2.5. Global DNA Repair Drugs Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global DNA Repair Drugs Market Value, 2017-2030, (US$ Mn))
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Drug Type
3.5.2. Application
3.5.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Drug Type Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global DNA Repair Drugs Market
7.1. Global DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
7.1.1. Overview
7.1.2. Global DNA Repair Drugs Market, By Drug Type, 2022 vs 2030 (in%)
7.1.3. Global DNA Repair Drugs Market, By Olaparib, 2017-2030 (US$ Mn))
7.1.4. Global DNA Repair Drugs Market, By Rucaparib, 2017-2030 (US$ Mn))
7.1.5. Global DNA Repair Drugs Market, By Niraparib, 2017-2030 (US$ Mn))
7.1.6. Global DNA Repair Drugs Market, By Talazoparib, 2017-2030 (US$ Mn))
7.1.7. Global DNA Repair Drugs Market, By Other Drug Types, 2017-2030 (US$ Mn))
7.2. Global DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
7.2.1. Overview
7.2.2. Global DNA Repair Drugs Market, By Application, 2022 vs 2030 (in%)
7.2.3. Global DNA Repair Drugs Market, By Ovarian Cancer, 2017-2030 (US$ Mn))
7.2.4. Global DNA Repair Drugs Market, By Fallopian Tube Cancer, 2017-2030 (US$ Mn))
7.2.5. Global DNA Repair Drugs Market, By Peritoneal Cancer, 2017-2030 (US$ Mn))
7.2.6. Global DNA Repair Drugs Market, By Breast Cancer, 2017-2030 (US$ Mn))
7.2.7. Global DNA Repair Drugs Market, By Other Application Types, 2017-2030 (US$ Mn))
7.3. Global DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
7.3.1. Overview
7.3.2. Global DNA Repair Drugs Market, By Distribution Channel, 2022 vs 2030 (in%)
7.3.3. Global DNA Repair Drugs Market, By Hospital Pharmacies, 2017-2030 (US$ Mn))
7.3.4. Global DNA Repair Drugs Market, By Retail Pharmacies, 2017-2030 (US$ Mn))
7.3.5. Global DNA Repair Drugs Market, By Other Distribution Channel, 2017-2030 (US$ Mn))

8. North America DNA Repair Drugs Market Analysis
8.1. North America DNA Repair Drugs Market, by Drug Type, 2017-2030(US$ Mn))
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America DNA Repair Drugs Market, by Application, 2017-2030(US$ Mn))
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America DNA Repair Drugs Market, by Distribution Channel, 2017-2030(US$ Mn))
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America DNA Repair Drugs Market, by Country, 2017-2030 (US$ Mn))
8.4.1. U.S.
8.4.1.1. U.S. DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
8.4.1.2. U.S. DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
8.4.1.3. U.S. DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
8.4.1.4. U.S. DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
8.4.2. Canada
8.4.2.1. Canada DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
8.4.2.2. Canada DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
8.4.2.3. Canada DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
8.4.2.4. Canada DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))

9. Europe DNA Repair Drugs Market Analysis
9.1. Europe DNA Repair Drugs Market, by Drug Type, 2017-2030(US$ Mn))
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe DNA Repair Drugs Market, by Application, 2017-2030(US$ Mn))
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe DNA Repair Drugs Market, by Distribution Channel, 2017-2030(US$ Mn))
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe DNA Repair Drugs Market, by Country, 2017-2030 (US$ Mn))
9.4.1. Germany
9.4.1.1. Germany DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.4.1.2. Germany DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
9.4.1.3. Germany DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
9.4.1.4. Germany DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
9.4.2. France
9.4.2.1. France DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.4.2.2. France DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
9.4.2.3. France DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
9.4.2.4. France DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
9.4.3. UK
9.4.3.1. UK DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.4.3.2. UK DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
9.4.3.3. UK DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
9.4.3.4. UK DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
9.4.4. Italy
9.4.4.1. Italy DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.4.4.2. Italy DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
9.4.4.3. Italy DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
9.4.4.4. Italy DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
9.4.5. Spain
9.4.5.1. Spain DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.4.5.2. Spain DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
9.4.5.3. Spain DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
9.4.5.4. Spain DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
9.4.6.2. Rest of Europe DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
9.4.6.3. Rest of Europe DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
9.4.6.4. Rest of Europe DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))

10. Asia Pacific DNA Repair Drugs Market Analysis
10.1. Asia Pacific DNA Repair Drugs Market, by Drug Type, 2017-2030(US$ Mn))
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific DNA Repair Drugs Market, by Application, 2017-2030(US$ Mn))
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific DNA Repair Drugs Market, by Distribution Channel, 2017-2030(US$ Mn))
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific DNA Repair Drugs Market, by Country, 2017-2030 (US$ Mn))
10.4.1. China
10.4.1.1. China DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.4.1.2. China DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
10.4.1.3. China DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
10.4.1.4. China DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
10.4.2. Japan
10.4.2.1. Japan DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.4.2.2. Japan DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
10.4.2.3. Japan DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
10.4.2.4. Japan DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
10.4.3. India
10.4.3.1. India DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.4.3.2. India DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
10.4.3.3. India DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
10.4.3.4. India DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
10.4.4. South Korea
10.4.4.1. South Korea DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.4.4.2. South Korea DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
10.4.4.3. South Korea DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
10.4.4.4. South Korea DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
10.4.5. South-East Asia
10.4.5.1. South-East Asia DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.4.5.2. South-East Asia DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
10.4.5.3. South-East Asia DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
10.4.5.4. South-East Asia DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
10.4.6.2. Rest of Asia Pacific DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
10.4.6.3. Rest of Asia Pacific DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
10.4.6.4. Rest of Asia Pacific DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))

11. Latin America DNA Repair Drugs Market Analysis
11.1. Latin America DNA Repair Drugs Market, by Drug Type, 2017-2030(US$ Mn))
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America DNA Repair Drugs Market, by Application, 2017-2030(US$ Mn))
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America DNA Repair Drugs Market, by Distribution Channel, 2017-2030(US$ Mn))
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America DNA Repair Drugs Market, by Country, 2017-2030 (US$ Mn))
11.4.1. Brazil
11.4.1.1. Brazil DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
11.4.1.2. Brazil DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
11.4.1.3. Brazil DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
11.4.1.4. Brazil DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
11.4.2. Mexico
11.4.2.1. Mexico DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
11.4.2.2. Mexico DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
11.4.2.3. Mexico DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
11.4.2.4. Mexico DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
11.4.3.2. Rest of Latin America DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
11.4.3.3. Rest of Latin America DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
11.4.3.4. Rest of Latin America DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))

12. Middle East and Africa DNA Repair Drugs Market Analysis
12.1. Middle East and Africa DNA Repair Drugs Market, by Drug Type, 2017-2030(US$ Mn))
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa DNA Repair Drugs Market, by Application, 2017-2030(US$ Mn))
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa DNA Repair Drugs Market, by Distribution Channel, 2017-2030(US$ Mn))
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa DNA Repair Drugs Market, by Country, 2017-2030 (US$ Mn))
12.4.1. GCC Countries
12.4.1.1. GCC Countries DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
12.4.1.2. GCC Countries DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
12.4.1.3. GCC Countries DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
12.4.1.4. GCC Countries DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
12.4.2. South Africa
12.4.2.1. South Africa DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
12.4.2.2. South Africa DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
12.4.2.3. South Africa DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
12.4.2.4. South Africa DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa DNA Repair Drugs Market Estimates and Forecast, 2017-2030 (US$ Mn))
12.4.3.2. Rest of Middle East and Africa DNA Repair Drugs, By Drug Type, 2017-2030 (US$ Mn))
12.4.3.3. Rest of Middle East and Africa DNA Repair Drugs, By Application, 2017-2030 (US$ Mn))
12.4.3.4. Rest of Middle East and Africa DNA Repair Drugs, By Distribution Channel, 2017-2030 (US$ Mn))
13. Company Profiles
13.1. Onxeo
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. FoRx Therapeutics
13.3. Artios Pharma Limited
13.4. Merck KGaA
13.5. Debiopharm Group
13.6. Breakpoint Therapeutics
13.7. Luciole Pharmaceuticals
13.8. Repare Therapeutics
13.9. AstraZeneca Plc
13.10. AbbVie
13.11. Johnson & Johnson
13.12. Pfizer Inc.
13.13. ClovisOncology Inc.
13.14. GlaxoSmithKline plc.

List of Figures
FIG. 1 Global DNA Repair Drugs Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global DNA Repair Drugs Market Segmentation
FIG. 4 Global DNA Repair Drugs Market, by Drug Type, 2022 (US$ Mn))
FIG. 5 Global DNA Repair Drugs Market, by Application, 2022 (US$ Mn))
FIG. 6 Global DNA Repair Drugs Market, by Distribution Channel, 2022 (US$ Mn))
FIG. 7 Global DNA Repair Drugs Market, by Geography, 2022 (US$ Mn))
FIG. 8 Attractive Investment Proposition, by Drug Type, 2022
FIG. 9 Attractive Investment Proposition, by Application, 2022
FIG. 10 Attractive Investment Proposition, by Distribution Channel, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key DNA Repair Drugs Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key DNA Repair Drugs Market Manufacturers, 2022
FIG. 14 Global DNA Repair Drugs Market Value Contribution, By Drug Type, 2022 & 2030 (Value %)
FIG. 15 Global DNA Repair Drugs Market, by Olaparib, Value, 2017-2030 (US$ Mn))
FIG. 16 Global DNA Repair Drugs Market, by Rucaparib, Value, 2017-2030 (US$ Mn))
FIG. 17 Global DNA Repair Drugs Market, by Niraparib, Value, 2017-2030 (US$ Mn))
FIG. 18 Global DNA Repair Drugs Market, by Talazoparib, Value, 2017-2030 (US$ Mn))
FIG. 19 Global DNA Repair Drugs Market, by Other Drug Types, Value, 2017-2030 (US$ Mn))
FIG. 20 Global DNA Repair Drugs Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 21 Global DNA Repair Drugs Market, by Ovarian Cancer, Value, 2017-2030 (US$ Mn))
FIG. 22 Global DNA Repair Drugs Market, by Fallopian Tube Cancer, 2017-2030 (US$ Mn))
FIG. 23 Global DNA Repair Drugs Market, by Peritoneal Cancer, 2017-2030 (US$ Mn))
FIG. 24 Global DNA Repair Drugs Market, by Breast Cancer, 2017-2030 (US$ Mn))
FIG. 25 Global DNA Repair Drugs Market, by Other Application Types, 2017-2030 (US$ Mn))
FIG. 26 Global DNA Repair Drugs Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 27 Global DNA Repair Drugs Market, by Hospital Pharmacies, Value, 2017-2030 (US$ Mn))
FIG. 28 Global DNA Repair Drugs Market, by Retail Pharmacies, 2017-2030 (US$ Mn))
FIG. 29 Global DNA Repair Drugs Market, by Other Distribution Channel, 2017-2030 (US$ Mn))
FIG. 30 North America DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 31 U.S. DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 32 Canada DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 33 Europe DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 34 Germany DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 35 France DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 36 U.K. DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 37 Italy DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 38 Spain DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 39 Rest of Europe DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 40 Asia Pacific DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 41 China DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 42 Japan DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 43 India DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 44 South Korea DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 45 South-East Asia DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 46 Rest of Asia Pacific DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 47 Latin America DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 48 Brazil DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 49 Mexico DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 50 Rest of Latin America DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 51 Middle East & Africa DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 52 GCC Countries DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 53 South Africa DNA Repair Drugs Market, 2017-2030 (US$ Mn))
FIG. 54 Rest of Middle East and Africa DNA Repair Drugs Market, 2017-2030 (US$ Mn))

List of Tables
TABLE 1 Market Snapshot: Global DNA Repair Drugs Market
TABLE 2 Global DNA Repair Drugs Market, by Competitive Benchmarking, 2022
TABLE 3 Global DNA Repair Drugs Market, by Geographical Presence Analysis, 2022
TABLE 4 Global DNA Repair Drugs Market, by Key Strategies Analysis, 2022
TABLE 5 Global DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 6 Global DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 7 Global DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 8 Global DNA Repair Drugs Market, by Geography, 2017-2030 (US$ Mn))
TABLE 9 North America DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 10 North America DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 11 North America DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 12 North America DNA Repair Drugs Market, by Country, 2017-2030 (US$ Mn))
TABLE 13 US DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 14 US DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 15 US DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 16 Canada DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 17 Canada DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 18 Canada DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 19 Europe DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 20 Europe DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 21 Europe DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 22 Europe DNA Repair Drugs Market, by Country, 2017-2030 (US$ Mn))
TABLE 23 Germany DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 24 Germany DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 25 Germany DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 26 France DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 27 France DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 28 France DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 29 UK DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 30 UK DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 31 UK DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 32 Italy DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 33 Italy DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 34 Italy DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 35 Spain DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 36 Spain DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 37 Spain DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 38 Rest of Europe DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 39 Rest of Europe DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 40 Rest of Europe DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 41 Asia Pacific DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 42 Asia Pacific DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 43 Asia Pacific DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 44 Asia Pacific DNA Repair Drugs Market, by Country, 2017-2030 (US$ Mn))
TABLE 45 China DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 46 China DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 47 China DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 48 Japan DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 49 Japan DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 50 Japan DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 51 India DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 52 India DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 53 India DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 54 South Korea DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 55 South Korea DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 56 South Korea DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 57 South-East Asia DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 58 South-East Asia DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 59 South-East Asia DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 60 Rest of Asia Pacific DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 61 Rest of Asia Pacific DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 62 Rest of Asia Pacific DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 63 Latin America DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 64 Latin America DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 65 Latin America DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 66 Latin America DNA Repair Drugs Market, by Country, 2017-2030 (US$ Mn))
TABLE 67 Brazil DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 68 Brazil DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 69 Brazil DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 70 Mexico DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 71 Mexico DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 72 Mexico DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 73 Rest of Latin America DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 74 Rest of Latin America DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 75 Rest of Latin America DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 76 Middle East and Africa DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 77 Middle East and Africa DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 78 Middle East and Africa DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 79 Middle East and Africa DNA Repair Drugs Market, by Country, 2017-2030 (US$ Mn))
TABLE 80 GCC Countries DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 81 GCC Countries DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 82 GCC Countries DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 83 South Africa DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 84 South Africa DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 85 South Africa DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))
TABLE 86 Rest of Middle East and Africa DNA Repair Drugs Market, by Drug Type, 2017-2030 (US$ Mn))
TABLE 87 Rest of Middle East and Africa DNA Repair Drugs Market, by Application, 2017-2030 (US$ Mn))
TABLE 88 Rest of Middle East and Africa DNA Repair Drugs Market, by Distribution Channel, 2017-2030 (US$ Mn))

Frequently asked questions

How does COVID-19 Impact the global DNA repair drugs market?

COVID-19 has had a substantial impact on the market due to the outbreak of the COVID-19 pandemic. Since cancer treatment was delayed throughout the world after the onset of the pandemic, the demand for these drugs significantly declined.

Which is the leading region of the market for DNA repair drugs market?

North America accounted for the most heightened share in the global DNA repair drugs market.

What are the key drivers for the growth of the DNA repair drugs market?

There is an increase in cancer incidence worldwide; increasing Oncology R&D Expenditures etc., is driving the DNA repair drugs market.

Which is the major segment in the DNA repair drugs market by drug type?

The olaparib segment had a major share in the global market in 2022.

Which is the major segment in the DNA repair drugs market by application?

The ovarian cancer segment had a major share in the global market.

Which is the major segment in the DNA repair drugs market by distribution channel?

The hospital pharmacies segment had a major share in the global market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –